Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Is Discussing Lamifiban Submission Based On Troponin T Substudy

Related Content

GP IIb/IIIa Meta-Analysis Would Not Provide Suitable Active Control - Cmte.

Oct 25 1999

Roche Tempium Discontinued Following Abnormal Liver Tests In Phase III

Sep 20 1999

Revascularization Should Not Be Endpoint For GP IIb/IIIa Inhibitors - Cmte.

Oct 18 1999

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window